论文部分内容阅读
目的观察普米克令舒、沐舒坦联合雾化吸入辅助治疗对婴幼儿毛细支气管炎的临床疗效。方法采用随机对照实验,选择毛细支气管炎76例,随机分为治疗组和对照组,观察其治疗前后疗效情况和其临床症状持续时间。结果普米克令舒、沐舒坦联合雾化吸入辅助治疗组疗效显著高于对照组,差异有显著性(P<0.05),并且其临床症状持续时间明显短于对照组,差异有显著性P<0.05。结论普米克令舒、沐舒坦联合雾化吸入辅助治疗可以缩短其临床症状持续时间,对婴幼儿毛细支气管炎的治疗,疗效确切,未见毒副作用。
Objective To observe the clinical efficacy of pulmicort respules and mucosolvan combined with nebulization in the treatment of infantile bronchiolitis. Methods Randomized controlled trials were conducted to select 76 patients with bronchiolitis and randomly divided into treatment group and control group. The curative effect and duration of clinical symptom before and after treatment were observed. Results Pulmicort respules and mucosolvan combined with inhalation adjuvant therapy group were significantly higher than the control group, the difference was significant (P <0.05), and the duration of clinical symptoms was significantly shorter than the control group, the difference was significant P < 0.05. Conclusions Pulmicort respules and mucosolvan combined with inhalation adjuvant therapy can shorten the duration of clinical symptoms. The treatment of infantile bronchiolitis has definite curative effect and no toxic or side effects.